What is the purpose of the Bortezomib 2mg Injection Bortrac?
The medication Bortezomib 2mg Injection Bortrac is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is likewise used to treat individuals with mantle cell lymphoma (a quickly developing disease that starts in the cells of the invulnerable framework). Bortezomib has a place in the class of meds known as antineoplastic specialists.
Is bortezomib a type of chemotherapy?
VELCADE (bortezomib) is a form of targeted treatment chemotherapy. VELCADE belongs to the proteasome inhibitors class of drugs. The FDA has given its an endorsement to treat various myeloma and mantle cell lymphoma.
How long can bortezomib be taken?
Bortezomib can be used alone if you’ve already had myeloma treatment. Bortezomib is usually used for two weeks at a time. After that, you get a ten-day rest. A treatment cycle is a three-week time of treatment.
What are the Bortezomib 2mg Injection Bortrac side effects?
- nausea, vomiting
- loss of appetite, diarrhea
- constipation, fatigue
- weakness or pain/redness at the injection site are all possible side effects.
- Nausea, vomiting, and diarrhea are all common side effects.
- Your primary care physician might prescribe medicine to forestall or ease queasiness, spewing or looseness of the bowels in certain conditions.
For more detail Click Here.
Is Bortezomib 2mg Injection Bortrac associated with hair loss?
Hair thinning. Going bald is definitely not an immediate result of Velcade, yet it very well may be brought about by different meds utilized close by it. Hair loss has been reported in those taking Velcade with the cytotoxic drug cyclophosphamide.
How is Bortezomib 2mg Injection Bortrac administered?
Bortezomib 1 mg powder for solution for injection is given twice weekly for two weeks at the recommended dose of 1.3 mg/m2 body surface area on days 1, 4, 8, and 11 of a 21-day treatment cycle. A treatment cycle is defined as a three-week period.
What is the reason for bortezomib in the treatment of various myeloma?
Bortezomib is a proteasome inhibitor, which is a form of treatment for myeloma. Proteasomes are enzymes found in all cells that are essential for cell function and growth. Bortezomib makes cancer cells more sensitive to its actions, leading them to die or stop growing.
Bortezomib 2mg Injection Bortrac is cytotoxic, right?
Bortezomib is a unique cytotoxic chemical entity that inhibits the proteasome’s proteolytic activity and, as a result, the destruction of polyubiquitinated proteins intended for proteasome catalysis.